Stockreport

Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Pa...

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com
PDF The primary analysis of investigational, once-nightly FT218 at 9 g demonstrated highly statistically significant (pOnce-nightly FT218 at 9 g was generally well-tolerated [Read more]